DATATRAK International, Inc., a leader in cloud-based, unified digital clinical technologies and related services for the clinical trials industry, completed a case study with AG Mednet. The study analyzes the partnership between DATATRAK and AG Mednet to successfully reduce queries in a recent trial with integrated technology. DATATRAK and AG Mednet worked together to create real-time conciliation of imaging submissions. Queries dropped 90 percent after implementation of integration resulting in increased productivity for the entire trial.
The Blog @AG Mednet
Although we are only one month in, 2016 has proven to be a year that is likely to reshape healthcare. Technology such as 3-D printing and virtual reality are now in high demand and rapidly growing in the U.S. market. In order to meet demand, advancements of these tools are allowing researchers to discover more about the human brain, explore new regions of a rat’s brain in clinical trials and inspire conversation at conferences and annual meetings.
Recent breakthroughs in clinical trials and imaging technology have us looking forward to the new year. For instance— scientists can now watch how cells respond to new medications at the most minute level ever observed, while researchers are getting more creative on how to deliver drugs to patients. We have found the following news that is allowing 2015 to close with a bang.
From vaccines designed to target cancer cells to a gene-editing technology that may treat a rare form of blindness, November has been a busy month for clinical trials and innovation. Here are just a few articles that caught our eye this month.
What do funding, wearable technology, mobile technology and pharming have in common? Clinical trial innovation. All of these topics and more are just a sprinkling of the major news from the clinical trial research world this month. Here are the stories that caught our eye:
What if, rather than an invasive biopsy, a doctor used a smartphone to diagnose a patient with cancer? Or used 3-D printed implants to regrow and reconnect loose ends of injured nerves?
Imagine a teddy bear that collects data from patients and helps understand their emotions. Or a way to diagnose concussions without using CTs. Or hearing your family’s voices for the first time.
Earlier this year the Food and Drug Administration released the Clinical Trial Imaging Endpoint Process Standards draft guidance for the clinical trial industry. According to the FDA, the purpose of the guidance is to assist sponsors in optimizing the quality of imaging data obtained in clinical trials intended to support approval of drugs and biological products. More specifically, the guidance focuses on imaging acquisition, display, archiving and interpretation process standards.
Major news this month about clinical trial transparency, what to do if a trial ‘fails,’ research breakthroughs and the next major areas for scientific and tech advances.
This month’s clinical trial news includes new imaging techniques for safer brain tumor removals. That’s positive, but we also have recent stories about the need for more patient participation in clinical trials and better trial design, which are also important topics to discuss.